Literature DB >> 21325416

Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV.

Nattawat Onlamoon1, Jaydip Das Gupta, Prachi Sharma, Kenneth Rogers, Suganthi Suppiah, Jeanne Rhea, Ross J Molinaro, Christina Gaughan, Beihua Dong, Eric A Klein, Xiaoxing Qiu, Sushil Devare, Gerald Schochetman, John Hackett, Robert H Silverman, François Villinger.   

Abstract

Xenotropic murine leukemia-related virus (XMRV) was identified in association with human prostate cancer and chronic fatigue syndrome. To examine the infection potential, kinetics, and tissue distribution of XMRV in an animal model, we inoculated five macaques with XMRV intravenously. XMRV established a persistent, chronic disseminated infection, with low transient viremia and provirus in blood lymphocytes during acute infection. Although undetectable in blood after about a month, XMRV viremia was reactivated at 9 months, confirming the chronicity of the infection. Furthermore, XMRV Gag was detected in tissues throughout, with wide dissemination throughout the period of monitoring. Surprisingly, XMRV infection showed organ-specific cell tropism, infecting CD4 T cells in lymphoid organs including the gastrointestinal lamina propria, alveolar macrophages in lung, and epithelial/interstitial cells in other organs, including the reproductive tract. Of note, in spite of the intravenous inoculation, extensive XMRV replication was noted in prostate during acute but not chronic infection even though infected cells were still detectable by fluorescence in situ hybridization (FISH) in prostate at 5 and 9 months postinfection. Marked lymphocyte activation occurred immediately postinfection, but antigen-specific cellular responses were undetectable. Antibody responses were elicited and boosted upon reexposure, but titers decreased rapidly, suggesting low antigen stimulation over time. Our findings establish a nonhuman primate model to study XMRV replication/dissemination, transmission, pathogenesis, immune responses, and potential future therapies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325416      PMCID: PMC3126245          DOI: 10.1128/JVI.02411-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  RNase L levels in peripheral blood mononuclear cells: 37-kilodalton/83-kilodalton isoform ratio is a potential test for chronic fatigue syndrome.

Authors:  Kiet Phong Tiev; Edith Demettre; Philippe Ercolano; Lionel Bastide; Bernard Lebleu; Jean Cabane
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  2',5'-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome.

Authors:  Marc Frémont; Karim El Bakkouri; Freya Vaeyens; C Vincent Herst; Kenny De Meirleir; Patrick Englebienne
Journal:  Exp Mol Pathol       Date:  2005-03-02       Impact factor: 3.362

3.  Assays for retroviral reverse transcriptase.

Authors:  A Telesnitsky; S Blain; S P Goff
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors.

Authors:  Beihua Dong; Sanggu Kim; Seunghee Hong; Jaydip Das Gupta; Krishnamurthy Malathi; Eric A Klein; Don Ganem; Joseph L Derisi; Samson A Chow; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-18       Impact factor: 11.205

Review 5.  Inflammation, infection, and prostate cancer.

Authors:  Eric A Klein; Robert Silverman
Journal:  Curr Opin Urol       Date:  2008-05       Impact factor: 2.309

6.  Unravelling intracellular immune dysfunctions in chronic fatigue syndrome: interactions between protein kinase R activity, RNase L cleavage and elastase activity, and their clinical relevance.

Authors:  Mira Meeus; Jo Nijs; Neil McGregor; Romain Meeusen; Guy De Schutter; Steven Truijen; Marc Frémont; Elke Van Hoof; Kenny De Meirleir
Journal:  In Vivo       Date:  2008 Jan-Feb       Impact factor: 2.155

7.  Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection.

Authors:  Nattawat Onlamoon; Kenneth Rogers; Ann E Mayne; Kovit Pattanapanyasat; Kazuyasu Mori; Francois Villinger; Aftab A Ansari
Journal:  Immunology       Date:  2008-02-05       Impact factor: 7.397

8.  Semen-derived amyloid fibrils drastically enhance HIV infection.

Authors:  Jan Münch; Elke Rücker; Ludger Ständker; Knut Adermann; Christine Goffinet; Michael Schindler; Steffen Wildum; Raghavan Chinnadurai; Devi Rajan; Anke Specht; Guillermo Giménez-Gallego; Pedro Cuevas Sánchez; Douglas M Fowler; Atanas Koulov; Jeffery W Kelly; Walther Mothes; Jean-Charles Grivel; Leonid Margolis; Oliver T Keppler; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

9.  An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV.

Authors:  Eiji Sato; Rika A Furuta; Takayuki Miyazawa
Journal:  Retrovirology       Date:  2010-12-20       Impact factor: 4.602

10.  Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

Authors:  Anatoly Urisman; Ross J Molinaro; Nicole Fischer; Sarah J Plummer; Graham Casey; Eric A Klein; Krishnamurthy Malathi; Cristina Magi-Galluzzi; Raymond R Tubbs; Don Ganem; Robert H Silverman; Joseph L DeRisi
Journal:  PLoS Pathog       Date:  2006-03-31       Impact factor: 6.823

View more
  26 in total

1.  XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).

Authors:  Jui Pandhare-Dash; Chinmay K Mantri; Yuanying Gong; Zhenbang Chen; Chandravanu Dash
Journal:  Prostate       Date:  2011-09-19       Impact factor: 4.104

2.  Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.

Authors:  Graham Simmons; Simone A Glynn; Anthony L Komaroff; Judy A Mikovits; Leslie H Tobler; John Hackett; Ning Tang; William M Switzer; Walid Heneine; Indira K Hewlett; Jiangqin Zhao; Shyh-Ching Lo; Harvey J Alter; Jeffrey M Linnen; Kui Gao; John M Coffin; Mary F Kearney; Francis W Ruscetti; Max A Pfost; James Bethel; Steven Kleinman; Jerry A Holmberg; Michael P Busch
Journal:  Science       Date:  2011-09-22       Impact factor: 47.728

3.  In vivo hypermutation of xenotropic murine leukemia virus-related virus DNA in peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteins.

Authors:  Ao Zhang; Hal Bogerd; Francois Villinger; Jaydip Das Gupta; Beihua Dong; Eric A Klein; John Hackett; Gerald Schochetman; Bryan R Cullen; Robert H Silverman
Journal:  Virology       Date:  2011-10-06       Impact factor: 3.616

4.  Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase.

Authors:  Verónica Barrioluengo; Yi Wang; Stuart F J Le Grice; Luis Menéndez-Arias
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

5.  No evidence of xenotropic murine leukemia virus-related virus transmission by blood transfusion from infected rhesus macaques.

Authors:  Dhanya K Williams; Teresa A Galvin; Yamei Gao; Christina O'Neill; Dustin Glasner; Arifa S Khan
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

Review 6.  XMRV and prostate cancer--a 'final' perspective.

Authors:  Karen S Sfanos; Amanda L Aloia; Angelo M De Marzo; Alan Rein
Journal:  Nat Rev Urol       Date:  2012-01-10       Impact factor: 14.432

7.  Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques.

Authors:  Gregory Q Del Prete; Mary F Kearney; Jon Spindler; Ann Wiegand; Elena Chertova; James D Roser; Jacob D Estes; Xing Pei Hao; Charles M Trubey; Abigail Lara; Kyeongeun Lee; Chawaree Chaipan; Julian W Bess; Kunio Nagashima; Brandon F Keele; Rhonda Macallister; Jeremy Smedley; Vinay K Pathak; Vineet N Kewalramani; John M Coffin; Jeffrey D Lifson
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

8.  XMRV: usage of receptors and potential co-receptors.

Authors:  Mohan Kumar Haleyur Giri Setty; Krishnakumar Devadas; Viswanath Ragupathy; Veerasamy Ravichandran; Shixing Tang; Owen Wood; Durga Sivacharan Gaddam; Sherwin Lee; Indira K Hewlett
Journal:  Virol J       Date:  2011-09-06       Impact factor: 4.099

9.  In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.

Authors:  Deanna Lee; Jaydip Das Gupta; Christina Gaughan; Imke Steffen; Ning Tang; Ka-Cheung Luk; Xiaoxing Qiu; Anatoly Urisman; Nicole Fischer; Ross Molinaro; Miranda Broz; Gerald Schochetman; Eric A Klein; Don Ganem; Joseph L Derisi; Graham Simmons; John Hackett; Robert H Silverman; Charles Y Chiu
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

10.  Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.

Authors:  Marta Curriu; Jorge Carrillo; Marta Massanella; Elisabet Garcia; Francesc Cunyat; Ruth Peña; Peter Wienberg; Cristina Carrato; Joan Areal; Margarita Bofill; Bonaventura Clotet; Julià Blanco; Cecilia Cabrera
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.